Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
21,445,520
-
Shares change
-
-85,934
-
Total reported value, excl. options
-
$123,954,000
-
Value change
-
-$565,189
-
Number of buys
-
14
-
Number of sells
-
-15
-
Price
-
$5.78
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q2 2019
43 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q2 2019.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,445,520 shares
of 133,765,508 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include JAYHAWK CAPITAL MANAGEMENT, L.L.C. (13,257,627 shares), RENAISSANCE TECHNOLOGIES LLC (2,826,896 shares), VANGUARD GROUP INC (1,199,330 shares), Rock Springs Capital Management LP (925,000 shares), Man Group plc (899,641 shares), NORGES BANK (797,026 shares), Quinn Opportunity Partners LLC (259,764 shares), CREDIT SUISSE AG/ (227,950 shares), Oasis Management Co Ltd. (206,062 shares), and SG Americas Securities, LLC (134,310 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.